Trial Profile
Combination of rituximab and methotrexate followed by rituximab and cytarabine in elderly patients with primary CNS lymphoma
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Cytarabine (Primary) ; Methotrexate (Primary) ; Rituximab (Primary) ; Folinic acid
- Indications B-cell lymphoma; CNS cancer; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- Acronyms CREMA
- 16 Nov 2018 New trial record